88IV - Public company info - Wuxi Biologics (Cayman) Inc.

Input the stock code or the company name

Wuxi Biologics (Cayman) Inc., 02269.HK - Cash Flow	2022-12	2021-12	2020-12	2019-12	2018-12	2017-12	2016-12	2015-12	2014-12
Net Cash Flow from Operating Activities	6,127,335	3,781,244	1,975,514	1,286,080	813,710	403,615	129,382	107,150	21,505
Net Cash Flow from Return on Investments & Servicing of Finance	11,540	-15,208	-3,909	3,817	79,755	-33,619	-30,399	-20,590	-2,556
Interest Received	112,593	67,992	78,635	53,618	79,755	3,149	0	0	0
Interest Paid	-108,239	-83,200	-82,544	-49,801	0	-36,768	-30,399	-2,531	-2,556
Dividend Received	8,315	0	0	0	0	0	0	0	0
Dividend Paid	-1,129	0	0	0	0	0	0	-18,059	0
Others	0	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	-585,662	-349,986	-94,238	-78,001	-52,103	-43,335	-47,461	0	0
Net Cash Flow from Investing Activities	-6,028,031	-9,669,662	-7,294,918	-4,547,548	-495,829	-2,216,400	-421,144	-336,216	-50,120
Additions to Fixed Assets	-5,868,390	-6,523,114	-6,024,780	-3,233,464	-1,340,586	-670,601	-428,883	-334,362	-51,044
Disposal of Fixed Assets	20,125	80,856	66,485	47,645	530	50	0	66	46
Increase in Investments	-10,098,514	-60,671,006	-18,028,821	-4,777,430	-1,057,205	-1,909,886	0	0	0
Decrease in Investments	8,937,049	56,982,317	18,172,289	3,748,613	1,444,708	1,275,430	0	0	0
Net Cash Flow with Related Parties	579,939	0	216,892	0	600	-278,083	-541,838	402,398	32,992
Others	401,760	461,285	-1,696,983	-332,912	456,124	-633,310	549,577	-404,318	-32,114
Net Cash Flow before Financing Activities	-474,818	-6,253,612	-5,417,551	-3,335,652	345,533	-1,889,739	-369,622	-249,656	-31,171
Net Cash Flow from Financing Activities	-2,483,353	8,292,659	6,648,188	5,462,624	3,206,824	2,266,075	363,162	397,990	32,992
New Loans	2,389,197	675,284	1,171,239	2,049,825	0	346,585	918,000	0	4,424
Loans Repayment	-2,684,215	-822,110	-349,859	-162,174	0	-1,238,616	-13,000	-4,408	-4,424
Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0	0
Equity Financing	36,180	10,956,600	5,609,916	3,574,973	3,206,224	3,436,189	0	0	0
Net Cash Flow with Related Parties	579,939	0	216,892	0	600	-278,083	-541,838	402,398	32,992
Others	-2,804,454	-2,517,115	0	0	0	0	0	0	0
Increase(Decrease) in Cash & Cash Equivalents	-2,958,171	2,039,047	1,230,637	2,126,972	3,552,357	376,336	-6,460	148,334	1,821
Cash & Cash Equivalents at Beginning of Year	9,003,280	7,095,735	6,205,496	4,084,395	503,881	169,102	158,229	5,948	4,176
Net Cash Flow due to Change in Exchange Rate/Others	350,113	-131,502	-340,398	-5,871	28,157	-41,557	17,333	3,947	-49
Cash & Cash Equivalents at End of Year	6,395,222	9,003,280	7,095,735	6,205,496	4,084,395	503,881	169,102	158,229	5,948
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	1	1	0	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Wuxi Biologics (Cayman) Inc. , 02269.HK